Clinical Trials Using Akt-1 Antisense Oligonucleotide WGI-0301
Review the clinical trials studying akt-1 antisense oligonucleotide wgi-0301 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1
- Status: ActiveLocation: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland